Literature DB >> 29437814

Isolated splenic mucormycosis in a case of aplastic anaemia.

Shefali K Sharma1, Prasanth Balasubramanian2, Bishan Radotra3, Manphool Singhal4.   

Abstract

Mucormycosis, a rare opportunistic infection seen in immunocompromised hosts, is caused by fungi of Mucorales family. It may be confined to the organs, such as rhinocerebral and pulmonary mucormycosis, or may cause disseminated infection. A 14-year-old boy presented to our clinic with fever and left upper quadrant abdominal pain, and on evaluation was found to have pancytopaenia, and imaging revealed ill-defined splenic collection with thrombus in the splenic vein. He was started on empirical intravenous antibiotics, followed by antifungals empirically as he did not show any improvement clinically. Eventually, splenectomy was done, which on histopathological examination revealed mucormycosis. The patient finally succumbed to his illness as he developed peritonitis and refractory shock. To date, only two cases of isolated splenic mucormycosis have been reported. Aggressive treatment is needed, which includes the use of antifungals (amphotericin B) and surgical debridement or resection of the involved tissues or organs. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  malignant and benign haematology; tropical medicine (infectious disease)

Mesh:

Substances:

Year:  2018        PMID: 29437814      PMCID: PMC5836678          DOI: 10.1136/bcr-2017-223243

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Splenic mucormycosis.

Authors:  E Pastor; R Esperanza; E Grau
Journal:  Haematologica       Date:  1999-04       Impact factor: 9.941

2.  Splenic and renal mucormycosis in a healthy host: successful management by aggressive treatment.

Authors:  Vikas Gupta; Shrawan Kumar Singh; Neerja Kakkar; Sanjay Jain; Naveen Kalra; Uma Nahar Sakia
Journal:  Trop Gastroenterol       Date:  2010 Jan-Mar

Review 3.  How I treat mucormycosis.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis
Journal:  Blood       Date:  2011-05-26       Impact factor: 22.113

Review 4.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

5.  Primary gastrointestinal mucormycosis in an immunocompetent person.

Authors:  B N Shiva Prasad; A Shenoy; K S Nataraj
Journal:  J Postgrad Med       Date:  2008 Jul-Sep       Impact factor: 1.476

6.  Angioinvasive pulmonary mucormycosis presenting as multiple bilateral pulmonary nodules in a patient without obvious predisposing factors.

Authors:  A Sharma; V Gupta; R S Singh; N Kakkar; S Singh; P Bambery
Journal:  Singapore Med J       Date:  2008-10       Impact factor: 1.858

  6 in total
  1 in total

1.  Isolated splenic mucormycosis secondary to diabetic ketoacidosis: a case report.

Authors:  Shuai Luo; Xiang Huang; Yao Li; Jinjing Wang
Journal:  BMC Infect Dis       Date:  2022-07-07       Impact factor: 3.667

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.